CURE’s kidney cancer page is an extensive resource of cancer information featuring the latest kidney cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on kidney cancer.
May 8th 2024
The Food and Drug Administration granted a Biologics License Application for subcutaneous Opdivo for potential approval.